SAMIRA SHOKOOR: Open Payments
NPI 1386294460 · RIVERSIDE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$440 in 13 payments from 9 companies in 2025. Trend: 2023 $523 · 2024 $596 · 2025 $440
Food & beverage: $440
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. | 1 | $149 |
| Boston Scientific Corporation | 3 | $109 |
| E.R. Squibb & Sons, L.L.C. | 2 | $37 |
| Stryker Corporation | 1 | $33 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Edwards Lifesciences Corporation | 1 | $29 |
| CARDIVA MEDICAL, INC. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Chiesi USA, Inc. | 1 | $14 |
Products named: SYMPLICITY G3, EMBLEM MRI S-ICD, FARAPULSE, FLOWTRIEVER CATHETER, S, LEQVIO, EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV), ELIQUIS, OPTOWIRE.
Industry payments across CA — which companies pay providers there.
